Streetbeat News

Stock Prices

TXT

Textron Inc (NYSE:TXT) shares surged after Q4 results showed a mixed performance with sales missing estimates but adjusted EPS beating expectations. Textron Aviation's revenues declined, while Bell and Industrial segments reported revenue growth. The company announced a restructuring plan expected to save $75 million annually. Textron also provided a positive FY24 outlook with higher revenue and EPS projections than consensus estimates, and shared plans for continued investments in new products and programs. Shares rose 7.97% to $85.65.

Portfolio Pulse from Lekha Gupta

January 24, 2024 | 4:32 pm

RDHL

Redhill Biopharma's stock is trading higher following the grant of U.S. patent #11878011, which covers a method for eradicating Helicobacter pylori infection in patients, irrespective of their body mass index.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:31 pm

RDHL

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock is trading higher after being granted a patent for a method to eradicate helicobacter pylori infections. The stock's volume is above average, with over 7.27 million shares traded compared to the 100-day average of 9.125 million. Additionally, Redhill announced that its investigational drugs, opaganib and RHB-107, showed a synergistic effect with remdesivir in an Ebola virus study. The company's shares have risen 22% to $1.09.

Portfolio Pulse from Erica Kollmann

January 24, 2024 | 4:30 pm

HPE

Hewlett Packard Inc. (NYSE:HPE) saw a slight increase in its stock price to $15.64, despite a decline over the past month and year. The article discusses the company's P/E ratio in comparison to the industry average, suggesting that HPE may be undervalued given its lower P/E ratio relative to the Technology Hardware, Storage & Peripherals industry. The P/E ratio is a tool for evaluating a company's market performance, but it should be used alongside other metrics and qualitative analysis for investment decisions.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 4:30 pm

EVAX

MRK

Evaxion Biotech's stock price increased following a 13G filing that revealed Merck & Co now holds an 11.4% stake in EVAX as of December 21, 2023. Additionally, EVAX announced an expanded commitment to developing tailored cancer vaccines.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:19 pm

EDVMF

Endeavour Mining (OTC:EDVMF) exceeded its 2023 production guidance with 1.1 million ounces of gold and $266 million in shareholder returns. The company is advancing with its Sabodala-Massawa and Lafigue mines, expecting production starts in Q2 2024 and Q2 2023, respectively. Despite positive developments and high gold prices, Endeavour's stock has fallen -23% YTD amid CEO dismissal over misconduct and a strike at the Houndé mine in Burkina Faso, which may affect 2024's production.

Portfolio Pulse from Stjepan Kalinic

January 24, 2024 | 4:17 pm

ELV

Elevance Health Inc (NYSE:ELV) reported Q4 2023 revenues of $42.45 billion, a 7% increase Y/Y, surpassing consensus estimates. Adjusted EPS was $5.62, slightly missing the $5.64 consensus. Profit declined 1% Y/Y to $856 million. Membership dropped by 570,000, with Medicaid enrollment down by over 1 million. The company increased its quarterly dividend by 10.1% to $1.63 per share and provided a 2024 outlook with flat-to-low-single digit revenue growth and adjusted EPS of over $37.10. ELV shares rose 2.53% to $484.13.

Portfolio Pulse from Vandana Singh

January 24, 2024 | 4:15 pm

LRN

Barrington Research analyst Alexander Paris has maintained an Outperform rating on Stride Inc. (NYSE:LRN) and increased the price target from $70 to $75. This adjustment suggests a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:09 pm

GETR

Getaround Inc (NYSE:GETR) stock surged 139% to $0.44 after securing a new debt facility with Mudrick Capital Management for up to $20 million. The funding supports Getaround's 2024 operating plan, with an initial draw of $5 million. This follows strong Q3 2023 results, with 42% revenue growth and a 52% trip contribution margin. Getaround also launched a new global app and website, and Jason Mudrick joined the board. Ahmed Fattouh stepped down from the board following the funding.

Portfolio Pulse from Henry Khederian

January 24, 2024 | 4:07 pm

JL

Shares of J-Long resumed trading but were halted again due to a circuit breaker being triggered, this time due to a downward move in the stock price.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:07 pm